Skip to Main Content

Paper Details

mRNA-1273 efficacy in a severe COVID-19 model: attenuated activation of pulmonary immune cells after challenge.
bioRxiv
8
2021
1273, COVID-19, Human, SARS, SARS-CoV, SARS-CoV-2, SARS-CoV-2 disease, Single, human, humans, immune cells, inflammatory cell, lymphocyte proportions, mRNA, mRNA-1273, mice, patients, pulmonary immune cells, severe acute respiratory syndrome coronavirus

Datasets

Release 1.2